These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37664046)

  • 21. MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study.
    Xiang Y; Li S; Wang H; Song M; Hu K; Wang F; Wang Z; Niu Z; Liu J; Cai Y; Li Y; Zhu X; Geng J; Zhang Y; Teng H; Wang W
    Clin Transl Radiat Oncol; 2023 Jan; 38():175-182. PubMed ID: 36471751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-Treatment Computed Tomography Radiomics for Predicting the Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Retrospective Study.
    Mao Y; Pei Q; Fu Y; Liu H; Chen C; Li H; Gong G; Yin H; Pang P; Lin H; Xu B; Zai H; Yi X; Chen BT
    Front Oncol; 2022; 12():850774. PubMed ID: 35619922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study.
    Petresc B; Lebovici A; Caraiani C; Feier DS; Graur F; Buruian MM
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer.
    Chiloiro G; Cusumano D; Romano A; Boldrini L; Nicolì G; Votta C; Tran HE; Barbaro B; Carano D; Valentini V; Gambacorta MA
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study.
    Boldrini L; Chiloiro G; Cusumano D; Yadav P; Yu G; Romano A; Piras A; Votta C; Placidi L; Broggi S; Catucci F; Lenkowicz J; Indovina L; Bassetti MF; Yang Y; Fiorino C; Valentini V; Gambacorta MA
    Radiol Med; 2024 Apr; 129(4):615-622. PubMed ID: 38512616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.
    Lee YD; Kim HG; Seo M; Moon SK; Park SJ; You MW
    Int J Colorectal Dis; 2024 May; 39(1):78. PubMed ID: 38789861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging-based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study.
    Hu T; Gong J; Sun Y; Li M; Cai C; Li X; Cui Y; Zhang X; Tong T
    MedComm (2020); 2024 Jul; 5(7):e609. PubMed ID: 38911065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiomics Signature Based on Support Vector Machines for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Li C; Chen H; Zhang B; Fang Y; Sun W; Wu D; Su Z; Shen L; Wei Q
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Shi X; Zhao M; Shi B; Chen G; Yao H; Chen J; Wan D; Gu W; He S
    Front Oncol; 2022; 12():916840. PubMed ID: 36016621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.
    Li Z; Ma X; Shen F; Lu H; Xia Y; Lu J
    BMC Med Imaging; 2021 Feb; 21(1):30. PubMed ID: 33593304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI radiomics signature to predict lymph node metastasis after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
    Fang Z; Pu H; Chen XL; Yuan Y; Zhang F; Li H
    Abdom Radiol (NY); 2023 Jul; 48(7):2270-2283. PubMed ID: 37085730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI-based Multiregional Radiomics for Pretreatment Prediction of Distant Metastasis After Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.
    Zhao R; Wan L; Chen S; Peng W; Liu X; Wang S; Li L; Zhang H
    Acad Radiol; 2024 Apr; 31(4):1367-1377. PubMed ID: 37802671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy.
    Wang L; Wu X; Tian R; Ma H; Jiang Z; Zhao W; Cui G; Li M; Hu Q; Yu X; Xu W
    Front Oncol; 2023; 13():1133008. PubMed ID: 36925913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomic features derived from pretherapeutic MRI predict chemoradiation response in locally advanced rectal cancer.
    Chou Y; Peng SH; Lin HY; Lan TL; Jiang JK; Liang WY; Hu YW; Wang LW
    J Chin Med Assoc; 2023 Apr; 86(4):399-408. PubMed ID: 36727777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
    Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiomic Features of Primary Rectal Cancers on Baseline T
    Antunes JT; Ofshteyn A; Bera K; Wang EY; Brady JT; Willis JE; Friedman KA; Marderstein EL; Kalady MF; Stein SL; Purysko AS; Paspulati R; Gollamudi J; Madabhushi A; Viswanath SE
    J Magn Reson Imaging; 2020 Nov; 52(5):1531-1541. PubMed ID: 32216127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomics signature as a new biomarker for preoperative prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Zhang Z; Jiang X; Zhang R; Yu T; Liu S; Luo Y
    Diagn Interv Radiol; 2021 May; 27(3):308-314. PubMed ID: 34003118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comprehensive Prediction Model Based on MRI Radiomics and Clinical Factors to Predict Tumor Response After Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Jiang H; Guo W; Yu Z; Lin X; Zhang M; Jiang H; Zhang H; Sun Z; Li J; Yu Y; Zhao S; Hu H
    Acad Radiol; 2023 Sep; 30 Suppl 1():S185-S198. PubMed ID: 37394412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External Validation of a Radiomics Model for the Prediction of Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Bordron A; Rio E; Badic B; Miranda O; Pradier O; Hatt M; Visvikis D; Lucia F; Schick U; Bourbonne V
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205826
    [No Abstract]   [Full Text] [Related]  

  • 40. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
    Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.